Scott Howell

Scott Howell, M.S., has over 30 years of experience in the field of analytical chemistry with emphasis on liquid chromatography, gas chromatography mass spectrometry, and most recently liquid chromatography triple quadrupole mass spectrometry (LC/MS/MS). Mr. Howell has been involved in several areas of scientific research, including the pharmacology of cancer drugs, the study of heme intermediary metabolism, the biochemistry of protein turnover, and 17 years studying the biochemistry of diabetic complications in the laboratory of PreventAGE Chief Scientific Officer, Dr. Paul Beisswenger. Mr. Howell brings his analytical expertise along with his other skills and experience from a broad range of clinically oriented research projects to PreventAGE. Mr. Howell received his MS degree from the University of Texas System Cancer Center M.D. Anderson Hospital in Houston, TX and has co-authored over 25 scientific publications.